Back to User profile » Dr Shashank Joshi

Papers published by Dr Shashank Joshi:

Original Research

Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India

Joshi S, Vora A, Venugopal K, Dadhich P, Daxini A, Bhagat S, Patil S, Barkate H

Pragmatic and Observational Research 2022, 13:33-41

Published Date: 27 May 2022

Clinical Trial Report

TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial

Joshi D, GJ P, Ghosh S, Mohanan A, Joshi S, Mohan V, Chowdhury S, Dutt C, Tandon N

Diabetes, Metabolic Syndrome and Obesity 2022, 15:615-631

Published Date: 25 February 2022

Review

Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries

Dutt C, Nunes Salles JE, Joshi S, Nair T, Chowdhury S, Mithal A, Mohan V, Kasliwal R, Sharma S, Tijssen J, Tandon N

Diabetes, Metabolic Syndrome and Obesity 2022, 15:451-465

Published Date: 16 February 2022

Review

Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy

Mohan V, Mithal A, Joshi SR, Aravind SR, Chowdhury S

Drug Design, Development and Therapy 2020, 14:2487-2501

Published Date: 24 June 2020